The Medical Affairs Company - Medical Affairs Solutions/Service Company
pharmatechoutlook

Pharma Tech Outlook: Pharma Tech Magazine

The Medical Affairs Company: Purpose-Driven and Strategic: The go-to Medical Affairs Partner

Follow The Medical Affairs Company on :

David Hahn, Worldwide Head, The Medical Affairs CompanyDavid Hahn, Worldwide Head The value of communication has always been immense for businesses. Within the context of the biopharmaceutical industry, the importance of communication becomes immeasurable.

Considering the variables in carrying a drug from its early development stages through to its commercialization, it is justified to assume only some in the value chain or from the same scientific community maintain the same level of expertise.

Translating science into a commercially agreeable language is absolutely critical. The responsibility of disseminating medical information effectively falls on the shoulders of a company’s medical affairs department. The task, in recent years, has grown more complex due to the many new discoveries and advancements made in the pharmaceutical and medical device manufacturing fields.

Consequently, companies are on the lookout for a robust team of experts who can cover every facet of medical affairs. Fortunately for them, with The Medical Affairs Company (TMAC), the search is over.

TMAC is one of the world’s leading medical affairs solutions providers, offering a comprehensive portfolio that promises to deliver the right message to the right people in the right way. It is solely dedicated to this tricky-to-navigate domain and fueled by a sense of unrivaled purpose to deliver on each client expectation. Its corporate objective is powerful; it seeks to empower through knowledge, advance healthcare, and enrich patients’ lives.

The world’s largest provider of Medical Science Liaisons (MSL), TMAC is a subsidiary of Parexel, a leading global clinical research organization (CRO) focused on the development and delivery of innovative new therapies to advance patient health. Being a part of a company that provides support early in the clinical development lifecycle allows for a natural transition to TMAC to create tailored solutions that address the challenges of companies preparing for launch.

There have been many changes across the pharmaceutical industry from a scientific, regulatory, compliance, and operations perspective. While industry professionals are trained to adjust rapidly in this environment, the same cannot be said for the rest of the community. Science and data continue to evolve and grow at an astounding pace. The complexity of this expansive information places tremendous strain on pharma and biotech companies trying to communicate the same throughout a product’s life cycle. Medical affairs professionals and MSLs provide this peer-to-peer medical education for key opinion leaders (KOL) and other healthcare providers.

However, physicians, patients, nurses, medical office staff, stakeholders, and many other players with a vested interest in a product’s development also require timely updated information customized to their needs. TMAC’s MSLs distinctly and compliantly engage with these audiences and glean timely insights that are then communicated back to further shape the data in a manner that ensures the highest standards of safety and effectiveness.

TMAC effortlessly maintains the edge in this regard. It understands these shifts in the market and is perfectly poised to educate people across medical disciplines and cement the value of medical affairs as a support function for projects of all sizes. It is also perceptive of how many organizations are strapped for resources—especially small and mid-size businesses (SMBs)—and under the pressure of their variable cost model.
The faster they deliver their message clearly, the better their chances of achieving the desired goals. TMAC possesses the necessary staff and connections to amplify an organization’s medical affairs efforts, allowing them to focus on core business operations of developing new products and improving patient care delivery.

“As experts in the space, we develop and expand focused medical affairs messages. TMAC’s professional staff helps clients disseminate data effectively and accurately to diverse stakeholders,” says David Hahn, Worldwide Head of TMAC.

TMAC’s services cover the full spectrum of strategy development and execution in medical affairs. Its portfolio includes the option to contract some of the best MSLs, clinical trial liaisons (CTL), and clinical nurse educators (CNE) in the industry, accompanied by call center services and exceptional recruitment capabilities. TMAC emboldens clients who lack the necessary medical affairs infrastructure or processes to ensure successful clinical outcomes and product launches through these offerings. Managing the confidence of investors and important stakeholders and mitigating risks is much simpler with TMAC’s quality support.

As experts in the space, we develop and expand focused medical affairs messages. tmac’s professional staff helps clients effectively and accurately disseminate data to diverse stakeholders


It works with some of the biggest names in the pharmaceutical industry and brings the same professionalism to SMBs, striving to be the ideal medical affairs partner. The consulting service of TMAC excels at understanding their exact project requirements. It then—powered by the staff’s extensive subject matter expertise—provides the necessary guidance layered by a tactical execution to profitably complete the project.

Clients can buy what they need, when they need it from a niche specialty medical affairs provider, when working with TMAC. They can leverage TMAC’s access to a massive network of global MSLs and CTLs and outsource their medical affairs operations with complete security. Its executive staffing service, TMAC Direct, connects clients with professionals who possess strong clinical, regulatory, and medical affairs experience, among other competencies. TMAC’s unique in-house full-time recruiting staff, an industry exclusive, ensures each candidate is thoroughly vetted and appropriately matched to meet client and candidate needs. It does not contract freelancers, investing time and money in finding ideal recruiting experts and building a robust field team. This investment helps clients find the perfect candidate to meet their project-specific goals. TMAC's entire recruiting team believes that staffing should not be transactional. The relationships they cultivate in both directions ensure properly placed resources for the success of their clients.

TMAC’s services are tailored according to each project’s detailed needs, where its business development team is involved until the operational team begins its processes. Hahn or an executive team member are always present with every customer launch from the get-go. Feeling the touch of true customer service is simply an inevitable byproduct of collaborating with TMAC.
“We bring a wealth of experience and base process templates refined over 25 years, allowing us to identify the best ways to start a program with new clients and who might be the finest possible hire for them,” says Hahn.

These services only scratch the surface of what TMAC offers the modern pharmaceutical marketplace. Powering it to provide these effective medical affairs services under one roof is Hahn and his team of veterans, benefiting clients from a cost, efficiency, and scale perspective.

Before elaborating on its people and their strong corporate culture is an example of how TMAC helped a client with its CTL services, showcasing its competencies as the go-to medical affairs partner. The objective involved enrolling a minimum of 68 subjects within a year for a 33-site, Phase 2, small fiber neuropathy investigational study that began in August 2017. Unfortunately, by the end of February, six months after the initiation of the study, only ten subjects had enrolled, and the chances of signing up more were grim.

The deadline soon approaching, the client reached out to TMAC for assistance in improving their screening and enrollment processes. TMAC deployed a team of four contract CTLs to tick off some critical boxes on its checklist. The first was identifying barriers to screening and enrollment, including clinical trial awareness, followed by mitigating these barriers. They also ensured regular contact with the sites to keep sponsors in the loop with real-time feedback on the screening and randomization of patients.

After the team successfully carried out its responsibilities, the client screened 29 subjects per month and enrolled 13, a great contrast with their previous numbers of 11 and 2, respectively.
  • We bring a wealth of experience and base process templates that have been refined over 25 years, allowing us to identify the best ways to start up a program with new clients and who might be the finest possible hire for them

TMAC’s brand reputation, highlighted by similar instances, continues to grow among medical communities worldwide. Its expertise is especially important in the industry since there is a dearth of experienced and talented medical affairs professionals. TMAC remains unfazed due to its most integral facet, its people.

Its workforce comprises the most qualified, driven, and dedicated medical professionals. Every employee is recruited after careful consideration and groomed to outperform the competition. More importantly, TMAC instills a sense of pride and accomplishment within each employee, motivating them to drive the highest degree of customer service for clients. People thrive in TMAC’s culture, impressing upon clients their dedication toward delivering on the growing global demands for medical affairs.

“We cultivate a people-first culture and believe in creating relationships before anything else. It has been our recipe for success for employee longevity and customer satisfaction,” states Hahn.

TMAC intends to continually invest in people and adopt the latest technologies to better serve its growing clientele. Having expanded operations outside the U.S., it seeks new opportunities in the Ex-US market and has hired various senior-level personnel to drive business in Europe and Asia. It is pouring significant resources into training, applicant tracking, and customer reporting systems to ensure it consistently exceeds client expectations. Its plans to pursue non-traditional life science sectors are just around the corner. TMAC is set to change how the world views medical affairs with passion and finesse like no other.
Share this Article:

Company
The Medical Affairs Company

Headquarters
Greater Atlanta Area, GA

Management
David Hahn, Worldwide Head

Description
The Medical Affairs Company (TMAC) provides a full range of flexible and customizable medical affairs solutions to meet an organization’s needs. Its services include contract field-based medical teams, medical information call center services, and medical affairs consulting, all designed to address company resource, timing, and budget challenges. TMAC is one of the world’s leading medical affairs solutions providers, offering a comprehensive portfolio that promises to deliver the right message to the right people in the right way. It is solely dedicated to this tricky-to-navigate domain and fueled by a sense of unrivaled purpose to deliver on each client expectation. The largest provider of Medical Science Liaisons (MSL), TMAC is a subsidiary of Parexel, a leading global clinical research organization (CRO) focused on the development and delivery of innovative new therapies to advance patient health.